-
Mashup Score: 3
An unprecedented wave of oncologist faculty leaving or planning to leave their institutions led ASCO to develop eight recommendations for academic medical centers.
Source: www.oncologynewscentral.comCategories: General Medicine NewsTweet
-
Mashup Score: 1Public Dollars, Private Profits? Cancer Drug’s Cost Sky High Despite Taxpayer Funding - 2 month(s) ago
Despite the government spending $74.5 million in public funding for research into enzalutamide, U.S. patients are left paying nearly $190,000 annually for it. This is just one example of a broader issue of unchecked drug prices.
Source: www.oncologynewscentral.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6
A recent article suggested that community doctors lag in precision oncology. Ramy Sedhom, MD, defends the role of these oncologists in personalized cancer care.
Source: www.oncologynewscentral.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 8
Bishal Gyawali, MD, PhD, breaks down the 15 most common misunderstandings about the use of surrogate endpoints in oncology.
Source: www.oncologynewscentral.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12NCCN Issues Updated Guidance on Genetic Testing for Several Cancers - 5 month(s) ago
The NCCN recently updated guidelines for genetic testing in breast, ovarian, pancreatic, prostate, colorectal, endometrial, and gastric cancers.
Source: www.oncologynewscentral.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Doctors, Nurses Name Top Issues in Presidential Election - 6 month(s) ago
Do physicians and nurses prefer one candidate when it comes to healthcare issues? What concerns are driving their votes? Survey data reveal strong opinions.
Source: www.oncologynewscentral.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 21
Bishal Gyawali, MD, PhD, breaks down the 15 most common misunderstandings about the use of surrogate endpoints in oncology.
Source: www.oncologynewscentral.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Led by the American Economic Liberties Project, a handful of advocacy groups are urging the FTC to block two recently announced major cancer care acquisitions.
Source: www.oncologynewscentral.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 15“Absolutely Inhumane” Policy to End? COA Director Discusses Cancer Care Legislation - 7 month(s) ago
Ted Okon, MBA, executive director of COA, gives updates on key policy issues affecting oncology, including the Seniors Access to Critical Medications Act.
Source: www.oncologynewscentral.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3When Is Treating a Precursor Condition Harmful? - 7 month(s) ago
Trials testing treatments in the myeloma precursor condition MGUS have led some critics to say the approach is harming patients and the IRB should step in.
Source: www.oncologynewscentral.comCategories: General Medicine News, General HCPsTweet
Check my comments on @ASCO recent recommendations on Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists @OncNewsCentral @UAMSMyeloma ➡️ https://t.co/JtpzQ2Eghw